Intensity Therapeutics stockholders approve ESPP and re-elect directors at annual meeting

INTENSITY THERAPEUTICS, INC.

8,522,632 shares represented (~62.15% quorum) at July 17, 2024 annual meeting.
Daniel Donovan and Thomas I.H. Dubin re-elected as Class I directors until 2027.
Stockholders approved 2024 Employee Stock Purchase Plan (ESPP) with 6.6M for, 103k against.
EisnerAmper LLP ratified as independent auditor for fiscal year ending December 31, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.